Skip to main content

Advertisement

Log in

Potential outcome factors in subacute combined degeneration

Review of observational studies

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

BACKGROUND: Subacute combined degeneration is an acquired myelopathy caused by vitamin B12 deficiency. Therapy with B12 leads to improvement in most but to complete recovery in only a few patients. Prognostic indicators in subacute combined degeneration are unknown; therefore, predicting complete recovery of neurologic deficits is challenging.

PURPOSE: To identify potential correlates of outcome and to generate hypotheses concerning predictors of complete resolution of neurologic deficits in subacute combined degeneration.

DATA SOURCE: We searched EMBASE (1974 to October 2005), MEDLINE (1968 to October 2005), and references from identified reports.

REPORTS SELECTION: Reports of patients with subacute combined degeneration containing results of magnetic resonance imaging (MRI) and description of outcome and 1 patient treated by the authors.

DATA EXTRACTION, SYNTHESIS: We extracted data from 45 reports and 57 patients (36 males, 21 females: age range: 10 to 81) with a diagnosis of subacute combined degeneration, and estimated the strength of association between clinical, laboratory, and radiological factors and complete resolution of signs and symptoms.

RESULTS: Eight patients (14%) achieved clinical resolution and 49 (86%) improved with B12 therapy. The absence of sensory dermatomal deficit, Romberg, and Babinski signs were associated with a higher complete resolution rate. Patients with MRI lesions in ≤7 segments and age less than 50 also appear to have higher rates of complete resolution.

CONCLUSIONS: B12 therapy is reported to stop progression and improve neurologic deficits in most patients with subacute combined degeneration. However, complete resolution only occurs in a small percentage of patients and appears to be associated with factors suggestive of less severe disease at the time of diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Healton EB, Savage DG, Brust JC, Garrett TJ, Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore). 1991;70:229–45.

    CAS  Google Scholar 

  2. Stabler SP, Allen RH, Savage DG, Lindenbaum J. Clinical spectrum and diagnosis of cobalamin deficiency. Blood. 1990;76:871–81.

    PubMed  CAS  Google Scholar 

  3. Shevell MI, Rosenblatt DS. The neurology of cobalamin. Can J Neurol Sci. 1992;19:472–86.

    PubMed  CAS  Google Scholar 

  4. Licht DJ, Berry GT, Brooks DG, Younkin DP. Reversible subacute combined degeneration of the spinal cord in a 14-year-old due to a strict vegan diet. Clin Pediatr (Philadelphia). 2001;40:413–5.

    Article  CAS  Google Scholar 

  5. Scalabrino G. Subacute combined degeneration one century later. The neurotrophic action of cobalamin (vitamin B12) revisited. J Neuropathol Exp Neurol. 2001;60:109–20.

    PubMed  CAS  Google Scholar 

  6. Stabler SP, Allen RH. Vitamin B12 deficiency as a worldwide problem. Annu Rev Nutr. 2004;24:299–326.

    Article  PubMed  CAS  Google Scholar 

  7. Scalabrino G. Cobalamin (vitamin B(12)) in subacute combined degeneration and beyond: traditional interpretations and novel theories. Exp Neurol. 2005;192:463–79.

    Article  PubMed  CAS  Google Scholar 

  8. Kinsella LJ, Green R. ‘Anesthesia paresthetica’: nitrous oxide-induced cobalamin deficiency. Neurology. 1995;45:1608–10.

    PubMed  CAS  Google Scholar 

  9. Pant SS, Asbury AK, Richardson EP Jr. The myelopathy of pernicious anemia. A neuropathological reappraisal. Acta Neurol Scand. 1968;44(suppl 5):1–36.

    PubMed  Google Scholar 

  10. Allen RH, Stabler SP, Savage DG, Lindenbaum J. Diagnosis of cobalamin deficiency 1: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol. 1990;34:90–8.

    Article  PubMed  CAS  Google Scholar 

  11. Lindenbaum J, Savage DG, Stabler SP, Allen RH. Diagnosis of cobalamin deficiency: II. Relative sensitivities of serum cobalamin, methylmalonic acid, and total homocysteine concentrations. Am J Hematol. 1990;34:99–107.

    Article  PubMed  CAS  Google Scholar 

  12. Naurath HJ, Joosten E, Riezler R, Stabler SP, Allen RH, Lindenbaum J. Effects of vitamin B12, folate, and vitamin B6 supplements in elderly people with normal serum vitamin concentrations. Lancet. 1995;346:85–9.

    Article  PubMed  CAS  Google Scholar 

  13. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med. 1988;318:1720–8.

    Article  PubMed  CAS  Google Scholar 

  14. Bax L. MIX: Meta-analysis with Interactive eXplanations. 1.1 ed; 2005. Available at: http://www.mix-for-meta-analysis.info/index.html.

  15. Savage DG, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Baillieres Clin Haematol. 1995;8:657–78.

    Article  PubMed  CAS  Google Scholar 

  16. Snow CF. Laboratory diagnosis of vitamin B12 and folate deficiency: a guide for the primary care physician. Arch Intern Med. 1999;159:1289–98.

    Article  PubMed  CAS  Google Scholar 

  17. Pennypacker LC, Allen RH, Kelly JP, et al. High prevalence of cobalamin deficiency in elderly outpatients. J Am Geriatr Soc. 1992;40:1197–204.

    PubMed  CAS  Google Scholar 

  18. Weimann J. Toxicity of nitrous oxide. Best Pract Res Clin Anaesthesiol. 2003;17:47–61.

    Article  PubMed  CAS  Google Scholar 

  19. Marie RM, Le Biez E, Busson P, et al. Nitrous oxide anesthesia-associated myelopathy. Arch Neurol. 2000;57:380–2.

    Article  PubMed  CAS  Google Scholar 

  20. Sesso RM, Iunes Y, Melo AC. Myeloneuropathy following nitrous oxide anesthaesia in a patient with macrocytic anaemia. Neuroradiology. 1999;41:588–90.

    Article  PubMed  CAS  Google Scholar 

  21. Pema PJ, Horak HA, Wyatt RH. Myelopathy caused by nitrous oxide toxicity. Am J Neuroradiol. 1998;19:894–6.

    PubMed  CAS  Google Scholar 

  22. Berger JR, Quencer R. Reversible myelopathy with pernicious anemia: clinical/MR correlation. Neurology. 1991;41:947–8.

    PubMed  CAS  Google Scholar 

  23. Tracey JP, Schiffman FJ. Magnetic resonance imaging in cobalamin deficiency. Lancet. 1992;339:1172–3.

    Article  PubMed  CAS  Google Scholar 

  24. Timms SR, Cure JK, Kurent JE. Subacute combined degeneration of the spinal cord: MR findings. Am J Neuroradiol. 1993;14:1224–7.

    PubMed  CAS  Google Scholar 

  25. Murata S, Naritomi H, Sawada T. MRI in subacute combined degeneration. Neuroradiology. 1994;36:408–9.

    Article  PubMed  CAS  Google Scholar 

  26. Tajima Y, Mito Y, Owada Y, Moriwaka F, Tashiro K. MR appearance of subacute combined degeneration of the spinal cord. Jpn J Psychiatry Neurol. 1994;48:611–4.

    PubMed  CAS  Google Scholar 

  27. Wolansky LJ, Goldstein G, Gozo A, Lee HJ, Sills I, Chatkupt S. Subacute combined degeneration of the spinal cord: MRI detection of preferential involvement of the posterior columns in a child. Pediatr Radiol. 1995;25:140–1.

    Article  PubMed  CAS  Google Scholar 

  28. Rosener M, Dichgans J. Severe combined degeneration of the spinal cord after nitrous oxide anaesthesia in a vegetarian. J Neurol Neurosurg Psychiatry. 1996;60:354.

    PubMed  CAS  Google Scholar 

  29. Duprez TP, Gille M, Vande Berg BC, et al. MRI of the spine in cobalamin deficiency: the value of examining both spinal cord and bone marrow. Neuroradiology. 1996;38:511–5.

    Article  PubMed  CAS  Google Scholar 

  30. Larner AJ, Zeman AZ, Allen CM, Antoun NM. MRI appearances in subacute combined degeneration of the spinal cord due to vitamin B12 deficiency. J Neurol Neurosurg Psychiatry. 1997;62:99–100.

    PubMed  CAS  Google Scholar 

  31. Ng VW, Gross M, Clifton A. Case report: MR appearances in vitamin B12 neuropathy. Clin Radiol. 1997;52:394–6.

    Article  PubMed  CAS  Google Scholar 

  32. Rodriguez-Pena F, Repetto JA, Contreras A, Gomez-Cardenas E, Garcia-Vazquez F. Nuclear magnetic resonance in subacute combined degeneration of the spinal cord. A case report. Rev Neurol. 1997;25:2077–8.

    PubMed  CAS  Google Scholar 

  33. Felten D, Naccache L, Sarrazin J, Lapeyre E, Taillia H, Renard J. Pernicious anemia and subacute combined degeneration of the spinal cord: MR findings. Neurology. 1998;50(4 suppl 4):120.

    Google Scholar 

  34. Beltramello A, Puppini G, Cerini R, et al. Subacute combined degeneration of the spinal cord after nitrous oxide anaesthesia: role of magnetic resonance imaging. J Neurol Neurosurg Psychiatry. 1998;64:563–4.

    PubMed  CAS  Google Scholar 

  35. Yamada K, Shrier DA, Tanaka H, Numaguchi Y. A case of subacute combined degeneration: MRI findings. Neuroradiology. 1998;40:398–400.

    Article  PubMed  CAS  Google Scholar 

  36. Giron JM, Munoz A, Caro P, Rodriguez F, Vila MJ. Anestesia parestesica: aportacion de un nuevo caso y estudio evolutivo por resonancia magnetica. Neurologia. 1998;13:307–10.

    PubMed  CAS  Google Scholar 

  37. Karacostas D, Artemis N, Bairactaris C, Tsitourides I, Milonas I. Cobalamin deficiency: MRI detection of posterior columns involvement and posttreatment resolution. J Neuroimaging. 1998;8:171–3.

    PubMed  CAS  Google Scholar 

  38. Katsaros VK, Glocker FX, Hemmer B, Schumacher M. MRI of spinal cord and brain lesions in subacute combined degeneration. Neuroradiology. 1998;40:716–9.

    Article  PubMed  CAS  Google Scholar 

  39. Hemmer B, Glocker FX, Schumacher M, Deuschl G, Lucking CH. Subacute combined degeneration: clinical, electrophysiological, and magnetic resonance imaging findings. J Neurol Neurosurg Psychiatry. 1998;65:822–7.

    PubMed  CAS  Google Scholar 

  40. Yousry TA, Strupp M, Bruning R. Common variable immunodeficiency leading to spinal subacute combined degeneration monitored by MRI. J Neurol Neurosurg Psychiatry. 1998;64:663–6.

    PubMed  CAS  Google Scholar 

  41. Sharma S, Khilnani GC, Berry M. Case of the season. Megaloblastic anemia with subacute combined degeneration (SCD) of the spinal cord. Semin Roentgenol. 1999;34:2–4.

    Article  PubMed  CAS  Google Scholar 

  42. Bassi SS, Bulundwe KK, Greeff GP, Labuscagne JH, Gledhill RF. MRI of the spinal cord in myelopathy complicating vitamin B12 deficiency: two additional cases and a review of the literature. Neuroradiology. 1999;41:271–4.

    Article  PubMed  CAS  Google Scholar 

  43. Locatelli ER, Laureno R, Ballard P, Mark AS. MRI in vitamin B12 deficiency myelopathy. Can J Neurol Sci. 1999;26:60–3.

    PubMed  CAS  Google Scholar 

  44. Kuker W, Hesselmann V, Thron A, de Simone A. MRI demonstration of reversible impairment of the blood-CNS barrier function in subacute combined degeneration of the spinal cord. J Neurol Neurosurg Psychiatry. 1997;62:298–9.

    PubMed  CAS  Google Scholar 

  45. Warmuth-Metz M, Naumann M, Solymosi L. MRT bei funikularer Myelose. Rofo: Fortschr Geb Rontgenstr Nuklearmed. 1999;170:591–3.

    Google Scholar 

  46. Karantanas AH, Markonis A, Bisbiyiannis G. Subacute combined degeneration of the spinal cord with involvement of the anterior columns: a new MRI finding. Neuroradiology. 2000;42:115–7.

    Article  PubMed  CAS  Google Scholar 

  47. Yu MK, Rodgers GM. Detection of occult cobalamin deficiency by magnetic resonance imaging. Am J Hematol. 2000;65:83–4.

    Article  PubMed  CAS  Google Scholar 

  48. Ravina B, Loevner LA, Bank W. MR findings in subacute combined degeneration of the spinal cord: a case of reversible cervical myelopathy. Am J Roentgenol. 2000;174:863–5.

    CAS  Google Scholar 

  49. Coignard P, Lemesle M, Madinier G, et al. Interet de l’imagerie par resonance magnetique dans la sclerose combinee de la moelle par carence en vitamine B12. Rev Neurol (Paris). 2000;156:1000–4.

    CAS  Google Scholar 

  50. Jongen JC, Koehler PJ, Franke CL. Gecombineerde strengziekte door vitamine-B12-deficientie: eenvoudige diagnose, effectieve therapie. Ned Tijdschr Geneeskd. 2001;145:1229–33.

    PubMed  CAS  Google Scholar 

  51. Cornejo W, Gonzalez F, Toro ME, Cabrera D. Degeneracion combinada subaguda. Descripcion de un caso en un nino vegetariano estricto. Rev Neurol. 2001;33:1154–7.

    PubMed  CAS  Google Scholar 

  52. Ilniczky S, Jelencsik I, Kenez J, Szirmai I. MR findings in subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia—two cases. Eur J Neurol. 2002;9:101–4.

    Article  PubMed  CAS  Google Scholar 

  53. Beauchet O, Exbrayat V, Navez G, Blanchon MA, Quang BL, Gonthier R. Sclerose combinee medullaire revelatrice d’une carence en vitamine B12: particularites geriatriques a propos d’un cas evalue par imagerie par resonance magnetique nucleaire. Rev Med Intern. 2002;23:322–7.

    CAS  Google Scholar 

  54. Pittock SJ, Payne TA, Harper CM. Reversible myelopathy in a 34-year-old man with vitamin B12 deficiency. Mayo Clin Proc. 2002;77:291–4.

    Article  PubMed  Google Scholar 

  55. Srikanth SG, Jayakumar PN, Vasudev MK, Taly AB, Chandrashekar HS. MRI in subacute combined degeneration of spinal cord: a case report and review of literature. Neurol India. 2002;50:310–2.

    PubMed  CAS  Google Scholar 

  56. Penas M, Blanco A, Villarejo A, Juntas R, Miranda P, Martinez A. Degeneracion combinada subaguda medular: hallazgos en la resonancia magnetica. Neurologia. 2002;17:447–8.

    PubMed  CAS  Google Scholar 

  57. Krishna KK, Arafat AS, Ichaporia NR, Jain MM. MRI findings in cobalamin deficiency. J Clin Neurosci. 2003;10:84–5.

    Article  PubMed  Google Scholar 

  58. Fritschi J, Sturzenegger M. Spinal MRI supporting myelopathic origin of early symptoms in unsuspected cobalamin deficiency. Eur Neurol. 2003;49:146–50.

    Article  PubMed  Google Scholar 

  59. Berlit P, Ringelstein A, Liebig T. Spinal MRI precedes clinical improvement in subacute combined degeneration with B12 deficiency. Neurology. 2004;63:592.

    PubMed  Google Scholar 

  60. Ahn SC, Brown AW. Cobalamin deficiency and subacute combined degeneration after nitrous oxide anesthesia: a case report. Arch Phys Med Rehabil. 2005;86:150–3.

    Article  PubMed  Google Scholar 

  61. Naidich MJ, Ho SU. Case 87: subacute combined degeneration. Radiology. 2005;237:101–5.

    Article  PubMed  Google Scholar 

  62. Plotas AA, Stamoulis E, Kehagias D, Papadopoulos A, Lahanis SV. Subacute combined degeneration of the spinal cord. Eur Radiol. 2005;15:1775–8.

    Article  Google Scholar 

  63. Morishita A, Tomita H, Takaishi Y, Nishihara M, Kohmura E. A case of subacute combined degeneration of the spinal cord diagnosed by characteristic findings of magnetic resonance imaging: case report and review of 22 cases. No Shinkei Geka. 2005;33:489–95.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The authors have no conflicts of interest to report. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.

This research was supported in part by the Intramural Research Program of the NIH, NIH Clinical Center, Department of Anesthesia and Surgical Services.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vasconcelos, O.M., Poehm, E.H., McCarter, R.J. et al. Potential outcome factors in subacute combined degeneration. J GEN INTERN MED 21, 1063–1068 (2006). https://doi.org/10.1111/j.1525-1497.2006.00525.x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1111/j.1525-1497.2006.00525.x

Key words

Navigation